Table 1.
Results of interrupted time-series model examining the impact of the COVID-19 pandemic on Direct Acting. Antiviral utilization across the G7 countries.
| G7 Countries | Percent Change 1 (%) |
Change in Trend of Monthly Direct Acting Antiviral Utilization 2 |
|---|---|---|
| Canada | −18 | p = 0.0299 |
| France | −37 | p = 0.3399 |
| Germany | −19 | p = 0.0150 |
| Italy | −58 | p = 0.2008 |
| Japan | −28 | p = 0.7015 |
| United Kingdom | −32 | p = 0.0004 |
| United States of America | −24 | p = 0.0003 |
1Percent change calculation. March 2020–August 2020 compared to March 2019–August 2019. 2Time series analysis. Ramp from April 2020 to August 2020 (September 2018 to March 2020 compared to April 2020 to August 2020).